|
1
|
Stiller CA, Trama A, Serraino D, Rossi S,
Navarro C, Chirlaque MD and Casali PG; RARECARE Working Group, :
Descriptive epidemiology of sarcomas in Europe: Report from the
RARECARE project. Eur J Cancer. 49:684–695. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burningham Z, Hashibe M, Spector L and
Schiffman JD: The epidemiology of Sarcoma. Clin Sarcoma Res.
2:142012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gustafson P and Arner M: Soft tissue
sarcoma of the upper extremity: Descriptive data and outcome in a
population-based series of 108 adult patients. J Hand Surg Am.
24:668–674. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gerrand CH, Wunder JS, Kandel RA,
O'Sullivan B, Catton CN, Bell RS, Bell RS, Griffin AM and Davis AM:
The influence of anatomic location on functional outcome in
lower-extremity soft-tissue sarcoma. Ann Surg Oncol. 11:476–482.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Müller DA, Beltrami G, Scoccianti G,
Frenos F and Capanna R: Combining limb-sparing surgery with
radiation therapy in high-grade soft tissue sarcoma of
extremities-is it effective? Eur J Surg Oncol. 42:1057–1063. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fletcher CDM, Unni KK and Mertens F: World
Health Organization Classification of Tumours. Pathology and
genetics of tumours of soft tissue and bone, IARC Press. pp.
Lyon2002
|
|
7
|
Lazerges C: Soft tissue sarcomas of the
forearm, wrist and hand. Hand Surg Rehabil. 36:233–243. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Strauss DC, Qureshi YA, Hayes AJ, Thway K,
Fisher C and Thomas JM: The role of core needle biopsy in the
diagnosis of suspected soft tissue tumours. J Surg Oncol.
102:523–529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Korah MP, Deyrup AT, Monson DK, Oskouei
SV, Weiss SW, Landry J and Godette KD: Anatomic tumor location
influences the success of contemporary limb-sparing surgery and
radiation among adults with soft tissue sarcomas of the
extremities. Int J Radiat Oncol Biol Phys. 82:933–939. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dailiana ZH, Bougioukli S, Varitimidis S,
Kontogeorgakos V, Togia E, Vlychou M and Malizos KN: Tumors and
tumor-like lesions mimicking carpal tunnel syndrome. Arch Orthop
Trauma Surg. 134:139–144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nandra R, Forsberg J and Grimer R: If your
lump is bigger than a golf ball and growing, think Sarcoma. Eur J
Surg Oncol. 41:1400–1405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Callister MD, Ballo MT, Pisters PW, Patel
SR, Feig BW, Pollock RE, Benjamin RS and Zagars GK: Epithelioid
sarcoma: Results of conservative surgery and radiotherapy. Int J
Radiat Oncol Biol Phys. 51:384–391. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kawai A, Hosono A, Nakayama R, Matsumine
A, Matsumoto S, Ueda T, Tsuchiya H, Beppu Y, Morioka H and Yabe H;
Japanese Musculoskeletal Oncology Group, : Clear cell sarcoma of
tendons and aponeuroses: A study of 75 patients. Cancer.
109:109–116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Walker EA, Salesky JS, Fenton ME and
Murphey MD: Magnetic resonance imaging of malignant soft tissue
neoplasms in the adult. Radiol Clin North Am. 491219–1234.
(vi)2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kransdorf MJ, Bancroft LW, Peterson JJ,
Murphey MD, Foster WC and Temple HT: Imaging of fatty tumors:
Distinction of lipoma and well-differentiated liposarcoma.
Radiology. 224:99–104. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vasileios KA, Eward WC and Brigman BE:
Surgical treatment and prognosis in patients with high-grade soft
tissue malignant fibrous histiocytoma of the extremities. Arch
Orthop Trauma Surg. 132:955–961. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heslin MJ, Lewis JJ, Woodruff JM and
Brennan MF: Core needle biopsy for diagnosis of extremity soft
tissue sarcoma. Ann Surg Oncol. 4:425–431. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Errani C, Traina F, Perna F, Calamelli C
and Faldini C: Current concepts in the biopsy of musculoskeletal
tumors. ScientificWorldJournal. 013:5381522013.
|
|
19
|
Khoo M, Pressney I, Hargunani R and
Saifuddin A: Small, superficial, indeterminate soft-tissue lesions
as suspected sarcomas: Is primary excision biopsy suitable?
Skeletal Radiol. 46:919–924. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van der Heijden L, Gibbons CL, Hassan AB,
Kroep JR, Gelderblom H, van Rijswijk CS, Nout RA, Bradley KM,
Athanasou NA, Dijkstra PD, et al: A multidisciplinary approach to
giant cell tumors of tendon sheath and synovium-a critical
appraisal of literature and treatment proposal. J Surg Oncol.
107:433–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Giuliano AE and Eilber FR: The rationale
for planned reoperation after unplanned total excision of
soft-tissue sarcomas. J Clin Oncol. 3:1344–1348. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Puhaindran ME, Rothrock CP and Athanasian
EA: Surgical management for malignant tumors of the thumb. Hand
(NY). 6:373–377. 2011. View Article : Google Scholar
|
|
23
|
Casali PG, Abecassis N, Aro HT, Bauer S,
Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG,
Brodowicz T, et al: Soft tissue and visceral sarcomas: ESMO-EURACAN
clinical practice guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 29 (Suppl 4):iv268–iv269. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Serpell JW, Ball AB, Robinson MH, Fryatt
I, Fisher C and Thomas JM: Factors influencing local recurrence and
survival in patients with soft tissue sarcoma of the upper limb. Br
J Surg. 78:1368–1372. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin PP, Guzel VB, Pisters PWT, Zagars GK,
Weber KL, Feig BW, Pollock RE and Yasko AW: Surgical management of
soft tissue sarcomas of the hand and foot. Cancer. 95:852–861.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Perloff M and Holland JF: Surgical
adjuvant chemotherapy. Annu Rev Med. 28:475–488. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosenberg SA, Kent H, Costa J, Webber BL,
Young R, Chabner B, Baker AR, Brennan MF, Chretien PB, Cohen MH, et
al: Prospective randomized evaluation of the role of limb-sparing
surgery, radiation therapy, and adjuvant chemoimmunotherapy in the
treatment of adult soft-tissue sarcomas. Surgery. 84:62–69.
1978.PubMed/NCBI
|
|
28
|
Alamanda VK, Crosby SN, Archer KR, Song Y,
Schwartz HS and Holt GE: Amputation for extremity soft tissue
sarcoma does not increase overall survival: A retrospective cohort
study. Eur J Surg Oncol. 38:1178–1183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Blay JY, Soibinet P, Penel N, Bompas E,
Duffaud F, Stoeckle E, Mir O, Adam J, Chevreau C, Bonvalot S, et
al: Improved survival using specialized multidisciplinary board in
sarcoma patients. Ann Oncol. 28:2852–2859. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cantin J, McNeer GP, Chu FC and Booher RJ:
The problem of local recurrence after treatment of soft tissue
sarcoma. Ann Surg. 168:47–53. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. Clin
Orthop Relat Res. 106–120. 1980.PubMed/NCBI
|
|
32
|
Harati K, Goertz O, Pieper A, Daigeler A,
Joneidi-Jafari H, Niggemann H, Stricker I and Lehnhardt M: Soft
Tissue sarcomas of the extremities: Surgical margins can be close
as long as the resected tumor has no ink on it. Oncologist.
22:1400–1410. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pradhan A, Cheung YC, Grimer RJ, Peake D,
Al-Muderis OA, Thomas JM and Smith M: Soft-tissue sarcomas of the
hand: Oncological outcome and prognostic factors. J Bone Joint Surg
Br. 90:209–214. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Puhaindran ME, Healey JH and Athanasian
EA: Single ray amputation for tumors of the hand. Clin Orthop Relat
Res. 468:1390–1395. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Puhaindran ME and Athanasian EA: Double
ray amputation for tumors of the hand. Clin Orthop Relat Res.
468:2976–2979. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tsukushi S, Nishida Y, Urakawa H, Arai E,
Kozawa E and Ishiguro N: Planned preservation surgery for soft
tissue sarcomas adjacent to critical structures. Arch Orthop Trauma
Surg. 133:481–486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Clarkson PW, Griffin AM, Cotton CN,
O'Sullivan B, Ferguson PC, Wunder JS and Bell RS: Epineural
dissection is a safe technique that facilitates limb salvage
surgery. Clin Orthop Relat Res. 438:92–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Radaelli S, Fiore M, Colombo C, Ford S,
Palassini E, Sanfilippo R, Stacchiotti S, Sangalli C, Morosi C,
Casali PG and Gronchi A: Vascular resection en-bloc with tumor
removal and graft reconstruction is safe and effective in soft
tissue sarcoma (STS) of the extremities and retroperitoneum. Surg
Oncol. 25:125–131. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Elias DA, White LM, Simpson DJ, Kandel RA,
Tomlinson G, Bell RS and Wunder JS: Osseous invasion by soft-tissue
sarcoma: Assessment with MR imaging. Radiology. 229:145–152. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ferguson PC, Griffin AM, O'Sullivan B,
Catton CN, Davis AM, Murji A, Bell RS and Wunder JS: Bone invasion
in extremity soft-tissue sarcoma: Impact on disease outcomes.
Cancer. 106:2692–2700. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lin PP, Pino ED, Normand AN, Deavers MT,
Cannon CP, Ballo MT, Pisters PW, Pollock RE, Lewis VO, Zagars GK
and Yasko AW: Periosteal margin in soft-tissue sarcoma. Cancer.
109:598–602. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Megerle K and Sauerbier M: Reconstructive
treatment of soft tissue sarcoma of the upper extremity. J Hand
Surg Am. 36:1241–1247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tseng JF, Ballo MT, Langstein HN, Wayne
JD, Cormier JN, Hunt KK, Feig BW, Yasko AW, Lewis VO, Lin PP, et
al: The effect of preoperative radiotherapy and reconstructive
surgery on wound complications after resection of extremity
soft-tissue sarcomas. Ann Surg Oncol. 13:1209–1215. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Weitz J, Antonescu CR and Brennan MF:
Localized extremity soft tissue sarcoma: Improved knowledge with
unchanged survival over time. J Clin Oncol. 21:2719–2725. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stojadinovic A, Leung DHY, Allen P, Lewis
JJ, Jaques DP and Brennan MF: Primary adult soft tissue sarcoma:
Time-dependent influence of prognostic variables. J Clin Oncol.
20:4344–4352. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Italiano A, Delva F, Mathoulin-Pelissier
S, Le Cesne A, Bonvalot S, Terrier P, Trassard M, Michels JJ, Blay
JY, Coindre JM and Bui B: Effect of adjuvant chemotherapy on
survival in FNCLCC grade 3 soft tissue sarcomas: A multivariate
analysis of the French sarcoma group database. Ann Oncol.
21:2436–2441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gronchi A, Casali PG, Mariani L, Miceli R,
Fiore M, Lo Vullo S, Bertulli R, Collini P, Lozza L, Olmi P and
Rosai J: Status of surgical margins and prognosis in adult soft
tissue sarcomas of the extremities: A series of patients treated at
a single institution. J Clin Oncol. 23:96–104. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jebsen NL, Trovik CS, Bauer HC, Rydholm A,
Monge OR, Hall KS, Alvegård T and Bruland OS: Radiotherapy to
improve local control regardless of surgical margin and malignancy
grade in extremity and trunk wall soft tissue sarcoma: A
Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys.
71:1196–1203. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang JC, Chang AE, Baker AR, Sindelar WF,
Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM,
Merino MJ and Rosenberg SA: Randomized prospective study of the
benefit of adjuvant radiation therapy in the treatment of soft
tissue sarcomas of the extremity. J Clin Oncol. 16:197–203. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Koshy M, Rich SE and Mohiuddin MM:
Improved survival with radiation therapy in high-grade soft tissue
sarcomas of the extremities: A SEER Analysis. Int J Radiat Oncol
Biol Phys. 77:203–209. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Davis AM, O'Sullivan B, Bell RS, Turcotte
R, Catton CN, Wunder JS, Chabot P, Hammond A, Benk V, Isler M, et
al: Function and health status outcomes in a randomized trial
comparing preoperative and postoperative radiotherapy in extremity
soft tissue sarcoma. J Clin Oncol. 20:4472–4477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pisters PWT, Pollock RE, Lewis VO, Yasko
AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G,
et al: Long-term results of prospective trial of surgery alone with
selective use of radiation for patients with T1 extremity and trunk
soft tissue sarcomas. Ann Surg. 246:675–682. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cahlon O, Brennan MF, Jia X, Qin LX,
Singer S and Alektiar KM: A postoperative nomogram for local
recurrence risk in extremity soft tissue sarcomas after
limb-sparing surgery without adjuvant radiation. Ann Surg.
255:343–347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Alektiar KM, Brennan MF, Healey JH and
Singer S: Impact of intensity-modulated radiation therapy on local
control in primary soft-tissue sarcoma of the extremity. J Clin
Oncol. 26:3440–3444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Folkert MR, Singer S, Brennan MF, Kuk D,
Qin LX, Kobayashi WK, Crago AM and Alektiar KM: Comparison of local
recurrence with conventional and intensity-modulated radiation
therapy for primary soft-tissue sarcomas of the extremity. J Clin
Oncol. 32:3236–3241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang J, Wang S, Song Y, Liu X, Jin J, Wang
W, Yu Z, Liu Y and Li Y: Postoperative intensity-modulated
radiation therapy provides favorable local control and low
toxicities in patients with soft tissue sarcomas in the extremities
and trunk wall. Onco Targets Ther. 8:2843–2847. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Tran QNH, Kim AC, Gottschalk AR, Wara WM,
Phillips TL, O'Donnell RJ, Weinberg V and Haas-Kogan DA: Clinical
outcomes of intraoperative radiation therapy for extremity
sarcomas. Sarcoma. 2006:916712006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Call JA, Stafford SL, Petersen IA and
Haddock MG: Use of intraoperative radiotherapy for upper-extremity
soft-tissue sarcomas: Analysis of disease outcomes and toxicity. Am
J Clin Oncol. 37:81–85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Pellizzon ACA: Evidence and clinical
outcomes of adult soft tissue sarcomas of the extremities treated
with adjuvant high-dose-rate brachytherapy-a literature review. J
Contemp Brachytherapy. 6:318–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Pisters PW, Harrison LB, Leung DH,
Woodruff JM, Casper ES and Brennan MF: Long-term results of a
prospective randomized trial of adjuvant brachytherapy in soft
tissue sarcoma. J Clin Oncol. 14:859–868. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tierney JF, Mosseri V, Stewart LA, Souhami
RL and Parmar MK: Adjuvant chemotherapy for soft-tissue sarcoma:
Review and meta-analysis of the published results of randomised
clinical trials. Br J Cancer. 72:469–475. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Pervaiz N, Colterjohn N, Farrokhyar F,
Tozer R, Figueredo A and Ghert M: A systematic meta-analysis of
randomized controlled trials of adjuvant chemotherapy for localized
resectable soft-tissue sarcoma. Cancer. 113:573–581. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Woll PJ, Reichardt P, Le Cesne A, Bonvalot
S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J,
Hogendoorn PC, et al: Adjuvant chemotherapy with doxorubicin,
ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC
62931): A multicentre randomised controlled trial. Lancet Oncol.
13:1045–1054. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Grobmyer SR, Maki RG, Demetri GD, Mazumdar
M, Riedel E, Brennan MF and Singer S: Neo-adjuvant chemotherapy for
primary high-grade extremity soft tissue sarcoma. Ann Oncol.
15:1667–1672. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gronchi A, Frustaci S, Mercuri M, Martin
J, Lopez-Pousa A, Verderio P, Mariani L, Valagussa P, Miceli R,
Stacchiotti S, et al: Short, full-dose adjuvant chemotherapy in
high-risk adult soft tissue sarcomas: A randomized clinical trial
from the Italian Sarcoma Group and the Spanish Sarcoma Group. J
Clin Oncol. 30:850–856. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Frustaci S, Gherlinzoni F, De Paoli A,
Bonetti M, Azzarelli A, Comandone A, Olmi P, Buonadonna A, Pignatti
G, Barbieri E, et al: Adjuvant chemotherapy for adult soft tissue
sarcomas of the extremities and girdles: Results of the Italian
randomized cooperative trial. J Clin Oncol. 19:1238–1247. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Gronchi A, Verderio P, De Paoli A, Ferraro
A, Tendero O, Majó J, Martin J, Comandone A, Grignani G,
Pizzamiglio S, et al: Quality of surgery and neoadjuvant combined
therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and
trunk wall. Ann Oncol. 24:817–823. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wray CJ, Benjamin RS, Hunt KK, Cormier JN,
Ross MI and Feig BW: Isolated limb perfusion for unresectable
extremity sarcoma: Results of 2 single-institution phase 2 trials.
Cancer. 117:3235–3241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Eggermont AM and ten Hagen TL: Isolated
limb perfusion for extremity soft-tissue sarcomas, in-transit
metastases, and other unresectable tumors: Credits, debits, and
future perspectives. Curr Oncol Rep. 3:359–367. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Cheney MD, Giraud C, Goldberg SI,
Rosenthal DI, Hornicek FJ, Choy E, Mullen JT, Chen YL and Delaney
TF: MRI surveillance following treatment of extremity soft tissue
sarcoma. J Surg Oncol. 109:593–596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Rothermundt C, Whelan JS, Dileo P, Strauss
SJ, Coleman J, Briggs TW, Haile SR and Seddon BM: What is the role
of routine follow-up for localised limb soft tissue sarcomas? A
retrospective analysis of 174 patients. Br J Cancer. 110:2420–2426.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Abatzoglou S, Turcotte RE, Adoubali A,
Isler MH and Roberge D: Local recurrence after initial
multidisciplinary management of soft tissue sarcoma: Is there a way
out? Clin Orthop Relat Res. 468:3012–3018. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Potter DA, Glenn J, Kinsella T, Glatstein
E, Lack EE, Restrepo C, White DE, Seipp CA, Wesley R and Rosenberg
SA: Patterns of recurrence in patients with high-grade soft-tissue
sarcomas. J Clin Oncol. 3:353–366. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Marulli G, Mammana M, Comacchio G and Rea
F: Survival and prognostic factors following pulmonary
metastasectomy for sarcoma. J Thorac Dis. 9 (Suppl 12):S1305–S1315.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Smith R, Pak Y, Kraybill W and Kane JM
III: Factors associated with actual long-term survival following
soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol.
35:356–3561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Borden EC, Amato DA, Rosenbaum C,
Enterline HT, Shiraki MJ, Creech RH, Lerner HJ and Carbone PP:
Randomized comparison of three adriamycin regimens for metastatic
soft tissue sarcomas. J Clin Oncol. 5:840–850. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Edmonson JH, Ryan LM, Blum RH, Brooks JS,
Shiraki M, Frytak S, Frytak S and Parkinson DR: Randomized
comparison of doxorubicin alone versus ifosfamide plus doxorubicin
or mitomycin, doxorubicin, and cisplatin against advanced soft
tissue sarcomas. J Clin Oncol. 11:1269–1275. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Antman K, Crowley J, Balcerzak SP, Rivkin
SE, Weiss GR, Elias A, Natale RB, Cooper RM, Barlogie B, Trump DL,
et al: An intergroup phase III randomized study of doxorubicin and
dacarbazine with or without ifosfamide and mesna in advanced soft
tissue and bone sarcomas. J Clin Oncol. 11:1276–1285. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Judson I, Verweij J, Gelderblom H,
Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan
J, Hohenberger P, et al: Doxorubicin alone versus intensified
doxorubicin plus ifosfamide for first-line treatment of advanced or
metastatic soft-tissue sarcoma: A randomised controlled phase 3
trial. Lancet Oncol. 15:415–423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Lilly Reports Results of Phase 3 Soft
Tissue Sarcoma Study of LARTRUVO®, . https://lilly.mediaroom.com/index.php?s=9042&item=137861January
18–2019
|
|
81
|
Frezza AM, Stacchiotti S and Gronchi A:
Systemic treatment in advanced soft tissue sarcoma: What is
standard, what is new. BMC Med. 15:1092017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Demetri GD, Von Mehren M, Jones RL,
Hensley ML, Schuetze SM, Staddon A, Milhem M, Elias A, Ganjoo K,
Tawbi H, et al: Efficacy and safety of trabectedin or dacarbazine
for metastatic liposarcoma or leiomyosarcoma after failure of
conventional chemotherapy: Results of a phase III randomized
multicenter clinical trial. J Clin Oncol. 34:786–793. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Maki RG, Wathen JK, Patel SR, Priebat DA,
Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D,
et al: Randomized phase II study of gemcitabine and docetaxel
compared with gemcitabine alone in patients with metastatic soft
tissue sarcomas: Results of sarcoma alliance for research through
collaboration study 002 [corrected]. J Clin Oncol. 25:2755–2763.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
García-del-Muro X, López-Pousa A, Maurel
J, Martín J, Martínez-Trufero J, Casado A, Gómez-España A, Fra J,
Cruz J, Poveda A, et al: Randomized phase II study comparing
gemcitabine plus dacarbazine versus dacarbazine alone in patients
with previously treated soft tissue sarcoma: A Spanish group for
research on sarcomas study. J Clin Oncol. 29:2528–2533. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Van Der Graaf WT, Blay JY, Chawla SP, Kim
DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP,
Beppu Y, et al: Pazopanib for metastatic soft-tissue sarcoma
(PALETTE): A randomised, double-blind, placebo-controlled phase 3
trial. Lancet. 379:1879–1886. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Young RJ, Litière S, Lia M, Hogendoorn
PCW, Fisher C, Mechtersheimer G, Daugaard S, Sciot R, Collin F,
Messiou C, et al: Predictive and prognostic factors associated with
soft tissue sarcoma response to chemotherapy: A subgroup analysis
of the European Organisation for research and treatment of cancer
62012 study. Acta Oncol. 56:1013–1020. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Gronchi A, Ferrari S, Quagliuolo V, Broto
JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge
RD, et al: Histotype-tailored neoadjuvant chemotherapy versus
standard chemotherapy in patients with high-risk soft-tissue
sarcomas (ISG-STS 1001): An international, open-label, randomised,
controlled, phase 3, multicentre trial. Lancet Oncol. 18:812–822.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Tawbi HA, Burgess M, Bolejack V, Van Tine
BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA,
et al: Pembrolizumab in advanced soft-tissue sarcoma and bone
sarcoma (SARC028): A multicentre, two-cohort, single-arm,
open-label, phase 2 trial. Lancet Oncol. 18:1493–1501. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Lee SH, Chang MH, Baek KK, Han B, Lim T,
Lee J and Park JO: High-dose ifosfamide as second- or third-line
chemotherapy in refractory bone and soft tissue sarcoma patients.
Oncology. 80:257–261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kawai A, Araki N, Sugiura H, Ueda T,
Yonemoto T, Takahashi M, Morioka H, Hiraga H, Hiruma T, Kunisada T,
et al: Trabectedin monotherapy after standard chemotherapy versus
best supportive care in patients with advanced,
translocation-related sarcoma: A randomised, open-label, phase 2
study. Lancet Oncol. 16:406–416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
de Necochea-Campion R, Zuckerman LM,
Mirshahidi HR, Khosrowpour S, Chen CS and Mirshahidi S: Metastatic
biomarkers in synovial sarcoma. Biomark Res. 5:42017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Kadoch C and Crabtree GR: Reversible
disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic
fusion in synovial sarcoma. Cell. 153:71–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Agulnik M, Tannir NM, Pressey JG, Gounder
MM, Cote GM, Roche M, Doleman S, Blakemore SJ, Clawson A, Daigle S,
et al: A phase II, multicenter study of the EZH2 inhibitor
tazemetostat in adult subjects with INI1-negative tumors or
relapsed/refractory synovial sarcoma. J Clin Oncol. 34:110712016.
View Article : Google Scholar
|
|
94
|
Pink D, Richter S, Gerdes S, Andreou D,
Tunn PU, Busemann C, Ehninger G, Reichardt P and Schuler MK:
Gemcitabine and docetaxel for epithelioid sarcoma: Results from a
retrospective, multi-institutional analysis. Oncology. 87:95–103.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Grivas A, Trafalis DT, Thanopoulou E,
Ziras NG and Athanasiou AE: Treatment with trabectedin: Should be
indicated to all soft tissue sarcoma histotypes? J BUON.
15:791–793. 2010.PubMed/NCBI
|
|
96
|
Cornillie J, van Cann T, Wozniak A, Hompes
D and Schöffski P: Biology and management of clear cell sarcoma:
State of the art and future perspectives. Expert Rev Anticancer
Ther. 16:839–845. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Wagner AJ, Goldberg JM, Dubois SG, Choy E,
Lee R, Pappo A, Geller J, Judson I, Hogg D, Senzer N, et al:
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients
with microphthalmia transcription factor-associated tumors: Results
of a multicenter phase 2 trial. Cancer. 118:5894–5902. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Schöffski P, Adkins D, Blay JY, Gil T,
Elias AD, Rutkowski P, Pennock GK, Youssoufian H, Gelderblom H,
Willey R and Grebennik DO: An open-label, phase 2 study evaluating
the efficacy and safety of the anti-IGF-1R antibody cixutumumab in
patients with previously treated advanced or metastatic soft-tissue
sarcoma or Ewing family of tumours. Eur J Cancer. 49:3219–3228.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Goldberg JM, Fisher DE, Demetri GD,
Neuberg D, Allsop SA, Fonseca C, Nakazaki Y, Nemer D, Raut CP,
George S, et al: Biologic activity of autologous,
granulocyte-macrophage colony-stimulating factor secreting alveolar
soft-part sarcoma and clear cell sarcoma vaccines. Clin Cancer Res.
21:3178–3186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
O'Sullivan B, Davis AM, Turcotte R, Bell
R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, et
al: Preoperative versus postoperative radiotherapy in soft-tissue
sarcoma of the limbs: A randomised trial. Lancet. 359:2235–2241.
2002. View Article : Google Scholar : PubMed/NCBI
|
